Statutory Instruments
2002 No. 3170
MEDICINES
The Medicines for Human Use (Kava-kava) (Prohibition) Order 2002
Made
18th December 2002
Laid before Parliament
23rd December 2002
Coming into force
13th January 2003
As respects England, Wales and Scotland, the Secretary of State concerned with health in England and as respects Northern Ireland, the Department of Health, Social Services and Public Safety, acting jointly, in exercise of the powers conferred upon them by section 62(1)(a) and (2) of the Medicines Act 1968 or, as the case may be, the powers conferred by those provisions and now vested in them , and of all other powers enabling them in that behalf, it appearing to them to be necessary in the interests of safety to make the following Order, after consulting such organisations as appear to them to be representative of interests likely to be substantially affected by the Order pursuant to section 129(6) of that Act, after consulting and taking into account the advice of the Committee on Safety of Medicines pursuant to sections 62(3) and 129(7) of that Act , and after taking into account the report of the Medicines Commission made under section 62(5) of that Act, hereby make the following Order:
Citation, commencement and interpretation
1. —(1) This Order may be cited as the Medicines for Human Use (Kava-kava) (Prohibition) Order 2002 and shall come into force on 13th January 2003.
(2) In this Order—
“the Act” means the Medicines Act 1968;
“ approved country for import ” has the meaning given in regulation 8(1) of the Human Medicines Regulations 2012;
...
...
“external use” means application to the skin, hair, teeth, mucosa of the mouth, throat, nose, ear, eye, vagina or anal canal when a local action only is intended and extensive systemic absorption is unlikely to occur, and references to medicinal products being “for external use” shall be read accordingly—except that such references shall not include throat sprays, throat pastilles, throat lozenges, throat tablets, nasal drops, nasal sprays, nasal inhalations or teething preparations;
...
“medicinal product” does not include a medicinal product which is a veterinary drug.
...
Prohibition of sale, supply and importation of any medicinal product consisting of or containing Piper methysticum (known as Kava-kava)
2. Subject to article 3 below, the sale, supply or importation of any medicinal product consisting of or containing—
(a) a plant belonging to the species Piper methysticum (known as Kava-kava); or
(b) an extract from such a plant,
is prohibited.
Exceptions to the prohibition imposed by article 2
3. The prohibition imposed by article 2 above shall not apply where the medicinal product is—
(a) for external use only;
(b) sold or supplied to, or is imported by or on behalf of, any of the following persons—
(i) an authorised officer within the meaning of section 5(6) of the Food Safety Act 1990 or Article 2(2) of the Food Safety (Northern Ireland) Order 1991 ,
(ii) a food analyst or food examiner within the meaning of section 30 of the Food Safety Act 1990 or Article 30 or 31 of the Food Safety (Northern Ireland) Order 1991 ,
(iii) a person duly authorised by an enforcement authority under sections 111 and 112 of the Act, or
(iv) a sampling officer within the meaning of Schedule 3 to the Act ;
(c) imported from an approved country for import, and is being, or is to be, exported to a country other than the United Kingdom; or
(d) the subject of a UK marketing authorisation, certificate of registration or traditional herbal registration within the meaning of the Human Medicines Regulations 2012.
Signed by authority of the Secretary of State for Health
Hunt
Parliamentary Under Secretary of State,
Department of Health
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety
D. C. Gowdy
Permanent Secretary,
Department of Health, Social Services and Public Safety